Global Polio Eradication Progress Described in 2022-2023 Surveillance Report
Is the world still making progress against polio? A two-year check-in
A worldwide surveillance report covering January 1, 2022, to December 31, 2023, describes progress toward polio eradication.
A global check-in confirms forward motion in the two-year fight to erase polio, keeping momentum alive against a disease that can paralyze c…
ACIP Updates Recommendations for Inactivated Polio Vaccine in U.S. Adults
U.S. health panel updates polio vaccine recommendations for adults
The Advisory Committee on Immunization Practices has issued updated recommendations for the use of inactivated polio vaccine in U.S.
U.S. health officials updated polio vaccine guidance for adults, clarifying who should get the shot and when based on existing evidence.
Respiratory panel PCR identifies neonatal enterovirus cluster in San Diego case report
San Diego hospital identifies cluster of enterovirus infections in newborns
A descriptive case report from San Diego documented use of respiratory viral panel PCR testing in neonates, identifying a cluster of enterov…
A San Diego hospital used a specific respiratory virus test to identify a cluster of enterovirus infections in newborns.
Countries revise polio emergency plans to intensify vaccination in underimmunized children
How are countries changing their fight to end polio for good?
A report describes revised emergency action plans to innovate and intensify polio vaccination strategies for children in underimmunized popu…
Countries fighting polio are changing their game plan to reach every child in hard-to-vaccinate areas where the virus still lingers.
COVID-19 immunization disruptions elevate polio risk in Africa and the Philippines
Did pandemic disruptions put kids at higher risk for polio?
A report describes how disruptions to routine immunizations during the COVID-19 pandemic have elevated the risk for increases in vaccine-pre…
Pandemic disruptions to childhood vaccines in Africa and the Philippines have raised the risk for outbreaks of dangerous diseases like polio…
New 6-in-1 infant vaccine licensed but availability delayed until at least 2021
New six-in-one vaccine for infants receives regulatory approval
A new combination vaccine for infants targeting diphtheria, tetanus, pertussis, polio, Hib, and hepatitis B has received licensure.
A new six-in-one vaccine for infants has received regulatory approval, but it won't be available for use until 2021 or later.